# Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects

> **NCT04098692** · PHASE1 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Derazantinib capsule
- **DRUG:** [14C]-Derazantinib solution for infusion
- **DRUG:** [14C]-Derazantinib capsule

## Key facts

- **NCT ID:** NCT04098692
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-08
- **Primary completion:** 2019-11-18
- **Final completion:** 2019-11-18
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04098692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04098692, "Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04098692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*